NEU neuren pharmaceuticals limited

Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-46

  1. 2,558 Posts.
    lightbulb Created with Sketch. 2661
    Gassy .I don’t think that Torreya discussions are dead in the water at all .I think the discussions would be very much ongoing.One of the problem getting USA pharma investors into the stock is that they would want a substantial investment in the company say $20 to $30 mill and won’t want to buy on the market as it would force the price up too much .The problem in a placement is that the company does not really need the money at this stage and would dilute existing shareholders too much .I think Friday’s trading was just the start of another momentum shift upwards !!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.99
Change
-0.110(0.84%)
Mkt cap ! $1.617B
Open High Low Value Volume
$13.20 $13.36 $12.82 $3.755M 287.6K

Buyers (Bids)

No. Vol. Price($)
12 659 $12.98
 

Sellers (Offers)

Price($) Vol. No.
$13.00 1232 19
View Market Depth
Last trade - 15.52pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.